UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 50

Sortiert nach

Quality control for retinal OCT in multiple sclerosis: validation of the OSCAR-IB criteria

Multiple sclerosis, 2015-02, Vol.21 (2), p.163-170

2015

Link zum Volltext

Verfügbarkeit prüfen

The genetic diversity of multiple sclerosis risk among Hispanic and African American populations living in the United States

Multiple sclerosis, 2020-10, Vol.26 (11), p.1329-1339

2020

Link zum Volltext

Verfügbarkeit prüfen

IL-6 induces regionally selective spinal cord injury in patients with the neuroinflammatory disorder transverse myelitis

The Journal of clinical investigation, 2005-10, Vol.115 (10), p.2731-2741

2005

Link zum Volltext

Verfügbarkeit prüfen

Pegylated interferon beta-1a for relapsing-remitting multiple sclerosis (ADVANCE): a randomised, phase 3, double-blind study

Lancet neurology, 2014-07, Vol.13 (7), p.657-665

2014

Link zum Volltext

Verfügbarkeit prüfen

Vitamin D status and effect of low-dose cholecalciferol and high-dose ergocalciferol supplementation in multiple sclerosis

Multiple sclerosis, 2009-06, Vol.15 (6), p.735-740

2009

Link zum Volltext

Verfügbarkeit prüfen

Intensity warping for multisite MRI harmonization

NeuroImage (Orlando, Fla.), 2020-12, Vol.223, p.117242-117242, Article 117242

2020

Link zum Volltext

Verfügbarkeit prüfen

Diagnosis and management of multiple sclerosis

American family physician, 2004-11, Vol.70 (10), p.1935-1944

Calabresi, Peter A

2004

Link zum Volltext

Verfügbarkeit prüfen

Therapeutic Application of Monoclonal Antibodies in Multiple Sclerosis

Clinical pharmacology and therapeutics, 2017-01, Vol.101 (1), p.52-64

2017

Link zum Volltext

Verfügbarkeit prüfen

Relation of Visual Function to Retinal Nerve Fiber Layer Thickness in Multiple Sclerosis

Ophthalmology (Rochester, Minn.), 2006-02, Vol.113 (2), p.324-332

2006

Link zum Volltext

Verfügbarkeit prüfen

The voltage-gated Kv1.3 K+ channel in effector memory T cells as new target for MS

The Journal of clinical investigation, 2003-06, Vol.111 (11), p.1703-1713

2003

Link zum Volltext

Verfügbarkeit prüfen

Targeting Effector Memory T Cells with a Selective Peptide Inhibitor of Kv1.3 Channels for Therapy of Autoimmune Diseases

Molecular pharmacology, 2005-04, Vol.67 (4), p.1369-1381

2005

Link zum Volltext

Verfügbarkeit prüfen

Idiopathic transverse myelitis: corticosteroids, plasma exchange, or cyclophosphamide

Neurology, 2007-05, Vol.68 (19), p.1614

2007

Link zum Volltext

Verfügbarkeit prüfen

Spotlight on Trans-Synaptic Degeneration in the Visual Pathway in Multiple Sclerosis

Eye and brain, 2023-01, Vol.15, p.153-160

2023

Link zum Volltext

Verfügbarkeit prüfen

Natalizumab plus Interferon Beta-1a for Relapsing Multiple Sclerosis

The New England journal of medicine, 2006-03, Vol.354 (9), p.911-923

2006

Link zum Volltext

Verfügbarkeit prüfen

The Voltage-Gated Potassium Channel Kv1.3 Is Highly Expressed on Inflammatory Infiltrates in Multiple Sclerosis Brain

Proceedings of the National Academy of Sciences - PNAS, 2005-08, Vol.102 (31), p.11094-11099

2005

Link zum Volltext

Verfügbarkeit prüfen

Association of Vitamin D Polygenic Risk Scores and Disease Outcome in People With Multiple Sclerosis

Neurology : neuroimmunology & neuroinflammation, 2023-01, Vol.10 (1)

2023

Link zum Volltext

Verfügbarkeit prüfen

Kv1.3-Blocking 5-Phenylalkoxypsoralens: A New Class of Immunomodulators

Molecular pharmacology, 2004-06, Vol.65 (6), p.1364-1374

2004

Link zum Volltext

Verfügbarkeit prüfen

Inhibition of FLT3 Signaling Targets DCs to Ameliorate Autoimmune Disease

Proceedings of the National Academy of Sciences - PNAS, 2005-11, Vol.102 (46), p.16741-16746

2005

Link zum Volltext

Verfügbarkeit prüfen

Cleavage of cystatin C in the cerebrospinal fluid of patients with multiple sclerosis

Annals of neurology, 2006-02, Vol.59 (2), p.237-247

2006

Link zum Volltext

Verfügbarkeit prüfen

Considerations in the treatment of relapsing-remitting multiple sclerosis

Neurology, 2002-04, Vol.58 (8 Suppl 4), p.S10

Calabresi, Peter A

2002

Link zum Volltext

Verfügbarkeit prüfen

The utility of MRI in suspected MS: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology

Neurology, 2003-09, Vol.61 (5), p.602

2003

Link zum Volltext

Verfügbarkeit prüfen

Association of human herpes virus 6 (HHV-6) with multiple sclerosis: Increased IgM response to HHV-6 early antigen and detection of serum HHV-6 DNA

Nature medicine, 1997-12, Vol.3 (12), p.1394-1397

1997

Link zum Volltext

Verfügbarkeit prüfen

Interferon-beta-1b slows progression of atrophy in RRMS: Three-year follow-up in NAb- and NAb+ patients

Neurology, 2004-03, Vol.62 (5), p.719

2004

Link zum Volltext

Verfügbarkeit prüfen

Interferon-beta-1a induces increases in vascular cell adhesion molecule: implications for its mode of action in multiple sclerosis

Journal of neuroimmunology, 2005-04, Vol.161 (1-2), p.169-176

2005

Link zum Volltext

Verfügbarkeit prüfen

Phase 1 trial of transforming growth factor beta 2 in chronic progressive MS

Neurology, 1998-07, Vol.51 (1), p.289

1998

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 50

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(49)
Mit Volltextzugriff
(40)

Publikationsform

Artikel
(50)

Sprache

Englisch
(50)
Japanisch
(10)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Quality control for retinal OCT in multiple sclerosis: validation of the OSCAR-IB criteria

The genetic diversity of multiple sclerosis risk among Hispanic and African American populations living in the United States

IL-6 induces regionally selective spinal cord injury in patients with the neuroinflammatory disorder transverse myelitis

Pegylated interferon beta-1a for relapsing-remitting multiple sclerosis (ADVANCE): a randomised, phase 3, double-blind study

Vitamin D status and effect of low-dose cholecalciferol and high-dose ergocalciferol supplementation in multiple sclerosis

Intensity warping for multisite MRI harmonization

Diagnosis and management of multiple sclerosis

Therapeutic Application of Monoclonal Antibodies in Multiple Sclerosis

Relation of Visual Function to Retinal Nerve Fiber Layer Thickness in Multiple Sclerosis

The voltage-gated Kv1.3 K+ channel in effector memory T cells as new target for MS

Targeting Effector Memory T Cells with a Selective Peptide Inhibitor of Kv1.3 Channels for Therapy of Autoimmune Diseases

Idiopathic transverse myelitis: corticosteroids, plasma exchange, or cyclophosphamide

Spotlight on Trans-Synaptic Degeneration in the Visual Pathway in Multiple Sclerosis

Natalizumab plus Interferon Beta-1a for Relapsing Multiple Sclerosis

The Voltage-Gated Potassium Channel Kv1.3 Is Highly Expressed on Inflammatory Infiltrates in Multiple Sclerosis Brain

Association of Vitamin D Polygenic Risk Scores and Disease Outcome in People With Multiple Sclerosis

Kv1.3-Blocking 5-Phenylalkoxypsoralens: A New Class of Immunomodulators

Inhibition of FLT3 Signaling Targets DCs to Ameliorate Autoimmune Disease

Cleavage of cystatin C in the cerebrospinal fluid of patients with multiple sclerosis

Considerations in the treatment of relapsing-remitting multiple sclerosis

The utility of MRI in suspected MS: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology

Association of human herpes virus 6 (HHV-6) with multiple sclerosis: Increased IgM response to HHV-6 early antigen and detection of serum HHV-6 DNA

Interferon-beta-1b slows progression of atrophy in RRMS: Three-year follow-up in NAb- and NAb+ patients

Interferon-beta-1a induces increases in vascular cell adhesion molecule: implications for its mode of action in multiple sclerosis

Phase 1 trial of transforming growth factor beta 2 in chronic progressive MS

Suchergebnisse filtern